Search research articles
Contact Us
Filters
Showing results (121-130 of 142) with videos related to
Page
of 15
Sort By:
Science Signaling
|
February 18, 2016
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sébastien Viel, Antoine Marçais, Fernando Souza-Fonseca Guimaraes, et al.
Cancer Immunology Research
|
January 8, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
Elisa Gobbini, Margaux Hubert, Anne-Claire Doffin, et al.
Bulletin Du Cancer
|
April 4, 2012
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]
Isabelle Ray-Coquard, Franck Chauvin, Eric Leblanc, et al.
Cancer Research
|
July 28, 2012
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression
Vanja Sisirak, Julien Faget, Michael Gobert, et al.
Oncoimmunology
|
July 4, 2012
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
Manuarii Manuel, Olivier Tredan, Thomas Bachelot, et al.
Science Translational Medicine
|
January 24, 2024
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 11, 2014
Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells
Sreekumar Balan, Vincent Ollion, Nicholas Colletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial
Laetitia Collet, Maude Ardin, David Venet, et al.
Data in Brief
|
September 16, 2022
Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors
Jean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer
Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 142) with videos related to
Sort By:
Page
of 15
Science Signaling
|
February 18, 2016
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sébastien Viel, Antoine Marçais, Fernando Souza-Fonseca Guimaraes, et al.
Cancer Immunology Research
|
January 8, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
Elisa Gobbini, Margaux Hubert, Anne-Claire Doffin, et al.
Bulletin Du Cancer
|
April 4, 2012
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]
Isabelle Ray-Coquard, Franck Chauvin, Eric Leblanc, et al.
Cancer Research
|
July 28, 2012
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression
Vanja Sisirak, Julien Faget, Michael Gobert, et al.
Oncoimmunology
|
July 4, 2012
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
Manuarii Manuel, Olivier Tredan, Thomas Bachelot, et al.
Science Translational Medicine
|
January 24, 2024
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 11, 2014
Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells
Sreekumar Balan, Vincent Ollion, Nicholas Colletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial
Laetitia Collet, Maude Ardin, David Venet, et al.
Data in Brief
|
September 16, 2022
Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors
Jean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer
Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio, et al.
Page
of 15